Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

GPCR Desensitization

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Flow cytometry enables rapid evaluation of novel, new and niche antimicrobial agents.

Frontiers in microbiology·2026

Same author

Realizing the potential of agonistic antibody immunotherapy.

Nature reviews. Drug discovery·2026

Same author

PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.

Science immunology·2026

Same author

Fast-tracking fungal detection: a rapid flow cytometric method for the detection of yeasts in blood cultures.

Frontiers in microbiology·2026

Same author

Evaluation of common urine leukocyte dipsticks for diagnosing peritoneal dialysis (PD)-associated peritonitis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026

Same author

Geographic remoteness and chronic kidney disease outcomes: a population-based cohort study using linked pathology data.

BMC nephrology·2026

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

The platelet receptor CLEC-2 is active as a dimer.

Aleksandra A Watson¹, Charita M Christou, John R James

¹Henry Wellcome Building for Molecular Physiology, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.

|October 15, 2009

Summary

Platelet receptor CLEC-2 activation by snake venom or tumor proteins is mediated by spleen tyrosine kinase (Syk). Researchers discovered CLEC-2 forms dimers, enabling Syk to bind two motifs for potent platelet activation.

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jun 19, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Area of Science:

Immunology
Molecular Biology
Biochemistry

Background:

The C-type lectin-like receptor 2 (CLEC-2) is a key platelet receptor involved in immune responses and hemostasis.
CLEC-2 interacts with ligands like rhodocytin and podoplanin, initiating intracellular signaling cascades.
Spleen tyrosine kinase (Syk) is a crucial downstream signaling molecule in CLEC-2 mediated platelet activation.

Purpose of the Study:

To elucidate the mechanism by which a single YXXL motif in CLEC-2 interacts with spleen tyrosine kinase (Syk).
To understand how CLEC-2 signaling, typically requiring ITAM-like motifs, is initiated by a single tyrosine phosphorylation.

Main Methods:

Bioluminescence resonance energy transfer (BRET)
Coimmunoprecipitation
Recombinant protein expression
Analytical gel filtration chromatography
Surface plasmon resonance (SPR)
Western blotting
Multi-angle light scattering (MALS)
Analytical ultracentrifugation

Main Results:

CLEC-2 forms a non-disulfide-linked homodimer.
This dimeric structure of CLEC-2 provides a mechanism for spleen tyrosine kinase (Syk) interaction.
Each Syk molecule can potentially bind to two YXXL motifs, one from each CLEC-2 monomer.

Conclusions:

The dimeric nature of CLEC-2 is essential for efficient interaction with spleen tyrosine kinase (Syk).
This interaction explains how a single YXXL motif can trigger potent platelet activation.
Findings provide novel insights into immune receptor signaling and platelet function.